logo
Select company
Select metric
$ -340.63MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
2
Sector
4
Industry
5
History
-
$ 24.21Close
$ 11.02 - $ 25.71 52-Week Range
Ticker Information

Ticker

VRDN

Company Name

VIRIDIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIRIDIAN THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VRDN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 470K$ -341.1M$ -340.63M
3/31/2025$ 693K$ -305.27M$ -304.58M
12/31/2024$ 711K$ -266.9M$ -266.19M
9/30/2024$ 744K$ -253.98M$ -253.24M
6/30/2024$ 811K$ -225.35M$ -224.54M
3/31/2024$ 582K$ -215.86M$ -215.27M
12/31/2023$ 570K$ -235.89M$ -235.32M
9/30/2023$ 523K$ -215.56M$ -215.04M
6/30/2023$ 363K$ -197.24M$ -196.88M
3/31/2023$ 368K$ -171.68M$ -171.31M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIRIDIAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -29.33M.
  • Over the past 5 years, VIRIDIAN THERAPEUTICS INC's average EBITDA has been $ -173.08M.
  • The median EBITDA for VIRIDIAN THERAPEUTICS INC during this period was $ -156.1M
  • VIRIDIAN THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -29.33M.
  • The lowest EBITDA recorded by VIRIDIAN THERAPEUTICS INC in the same timeframe $ -340.63M

VIRIDIAN THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
JANX : JANUX THERAPEUTICS INC $ -103.56MBHVN : BIOHAVEN LTD $ -757.43MEWTX : EDGEWISE THERAPEUTICS INC $ -148.35METNB : 89BIO INC $ -442.18MCLNN : CLENE INC $ -24.75MABEO : ABEONA THERAPEUTICS INC $ 79.97MDYN : DYNE THERAPEUTICS INC $ -410.59MVERA : VERA THERAPEUTICS INC $ -208.58MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -8.95MCDTX : CIDARA THERAPEUTICS INC $ -116.09M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for VIRIDIAN THERAPEUTICS INC is calculated as follows: EBIT [ $ -29.59M ] + DepAmor [ $ 262K ]
(=) EBITDA [ $ -29.33M ]

VRDN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -340.63M

Minimum

Jun 30, 2025

$ -29.33M

Maximum

Sep 30, 2020

$ -173.08M

Average

$ -156.1M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M